Fabio P. Nunes
Johnson & Johnson (United States)(US)Universidade de Brasília(BR)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Neurofibromatosis and Schwannoma Cases, Allergic Rhinitis and Sensitization, Meningioma and schwannoma management, Asthma and respiratory diseases
Most-Cited Works
- → Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials(2020)368 cited
- → Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study(2018)306 cited
- → JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial(2017)271 cited
- → Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis(2020)270 cited
- → The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis(2020)165 cited
- → Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)(2018)